GLP-1 medications help support appetite regulation and blood sugar control to promote steady, sustainable weight management
Considering the consistency of the alterations in GLP-1R and microglia in the TNC, we predict that the main reason for the upregulation of GLP-1R is due to the increased number of microglia
Sustained adherence represents a major advantage: according to research from Northwestern Medicine, 50-75% of people who start taking standard-dose GLP-1 medications stop using them within a year
Yes, but do it tactfully
The test examines your GLP1R rs6923761 variant and 49 other peptide-pathway genes to estimate how strongly your body's receptors will respond to semaglutide
Trial data have shown decreases in serious cardiovascular complications, including cardiovascular mortality, nonlethal heart attacks, and nonfatal cerebrovascular accidents, among individuals with type 2 diabetes and pre-existing cardiovascular pathology or high cardiovascular risk [3,5,13,14,37]
